Treatment-of-choice for Buerger’s disease (thromboangiitis obliterans): still an unresolved issue

ISSN： 0770-3198

Source： Clinical Rheumatology, Vol.27, Iss.4, 2008-04, pp. : 547-547

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Intestinal Type of Thromboangiitis Obliterans (Buerger Disease) Preceding Symptoms of Severe Peripheral Arterial Disease

By Arkkila P. E. T. Kahri A. Färkkilä M.

Scandinavian Journal of Gastroenterology, Vol. 36, Iss. 6, 2001-06 ,pp. : 669-672

Informa Healthcare

Access to resources Recommend Favorite

Cerebral Vein Thrombosis in a Case with Thromboangiitis obliterans

Cerebrovascular Diseases, Vol. 9, Iss. 5, 1999-09 ,pp. : 295-297

Karger

Access to resources Recommend Favorite

THE EFFECT OF A 5HT 2 RECEPTOR ANTAGONIST SARPOGRELATE (MCI-9042) TREATMENT ON PLATELET FUNCTION IN BUERGER'S DISEASE

By Rydzewski A. Urano T. Hachiya T. Kaneko H. Baba S. Takada Y. Takada A.

Thrombosis Research, Vol. 84, Iss. 6, 1996-12 ,pp. : 445-452

Elsevier

Access to resources Recommend Favorite

Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis

By Kishida Dai

Modern Rheumatology, Vol. 21, Iss. 2, 2011-04 ,pp. : 215-218

Springer Publishing Company

Access to resources Recommend Favorite

Acute hepatitis in adult Still’s disease during corticosteroid treatment successfully treated with anakinra

By Mylona Eleni Golfinopoulou Styliani Samarkos Michael Fanourgiakis Panagiotis Papadakos Vasilios Skoutelis Athanasios

Clinical Rheumatology, Vol. 27, Iss. 5, 2008-05 ,pp. : 659-661

Springer Publishing Company

Access to resources Recommend Favorite